Consolidated Statements Of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net income	$ 349,115	$ 609,120
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	181,938	142,254
Net loss of equity method investments, inclusive of distributions	3,082	2,593
Loss on early extinguishment of debt attributable to unamortized discount	1,489	7,948
Deferred income taxes	(13,518)	(11,929)
Equity based compensation expense	13,846	17,192
Change in fair value - derivative instruments	486	(57,192)
(Increase) decrease in current assets:
Accounts receivable	(81,399)	(122,875)
Inventories	(150,585)	(230,811)
Income taxes receivable	90,501	12,526
Prepayments and other	3,171	10,040
Increase (decrease) in current liabilities:
Accounts payable	307,473	216,506
Accrued liabilities	20,865	(7,588)
Turnaround expenditures	(9,708)	(159,811)
Other, net	4,723	23,542
Net cash provided by operating activities	721,479	451,515
Cash flows from investing activities:
Additions to properties, plants and equipment	(205,987)	(153,942)
Proceeds from sale of properties, plants, and equipment	0	5,802
Investment in Sabine Biofuels	(5,000)	(2,000)
Net repayment of advances to Sabine Biofuels	10,021	(13,700)
Purchases of marketable securities	(498,080)	(399,154)
Sales and maturities of marketable securities	(543,604)	(398,762)
Net cash used for investing activities	(194,224)	(181,093)
Cash flows from financing activities:
Redemption of senior notes	0	(300,973)
Proceeds from sale of HEP common units	0	73,444
Proceeds from common unit offerings - HEP	0	146,888
Inventory repurchase obligation	5,964	0
Purchase of treasury stock	(20,135)	(159,432)
Dividends	(323,088)	(264,867)
Excess tax benefit from equity based compensation	3,778	1,037
Deferred financing costs and other	(433)	(2,184)
Net cash used for financing activities	(349,056)	(678,701)
Cash and cash equivalents:
Increase for the period	178,199	(408,279)
Beginning of period	940,103	1,757,699
End of period	1,118,302	1,349,420
Cash paid during the period for:
Interest	30,702	46,566
Income taxes	118,142	336,099
HEP [Member]
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	30,661	29,368
Cash flows from investing activities:
Additions to properties, plants and equipment	(38,782)	(16,861)
Cash flows from financing activities:
Borrowings under credit agreement - HEP	477,100	154,500
Repayments under credit agreement - HEP	(297,100)	(220,500)
Redemption of senior notes	(156,188)	0
Proceeds from common unit offerings - HEP		73,444
Distributions to noncontrolling interest	(38,548)	(34,604)
Purchase of units for incentive grants - HEP	(406)	(2,934)
Cash and cash equivalents:
Beginning of period	6,352
End of period	$ 6,066